A single cryoballoon ablation procedure results in high acute and medium-term efficacy rates for paroxysmal atrial fibrillation and lower success rates when used as stand-alone therapy for persistent ...

Please provide your email address to receive an email when new articles are posted on . Cryoballoon ablation was noninferior to radiofrequency ablation in patients with atrial fibrillation and HFrEF.

In patients with atrial fibrillation (A-fib), cryoballoon treatment offers long-term outcomes that rival those of radiofrequency ablation. The findings were published online November 28, 2012, ahead ...

Atrial fibrillation, a rapid and irregular heartbeat, is putting a growing number of Americans at risk of heart failure and stroke, and in turn dramatically increasing the clinical and financial ...

AF, the most common sustained atrial arrhythmia, is more common in men where the prevalence increases with increasing age. [1] AF can be paroxysmal (episodes terminate in less than seven days), ...

Editor's Note: A previous version of this press release incorrectly reported the rate of recurrence or subsequent treatment for atrial fibrillation for the two devices in this study at 64.1 percent ...

If one is going to write about procedural complications for the treatment of atrial fibrillation, it is imperative to begin with givens: First, the only guaranteed way to avoid complications is to ...

TORONTO, Nov. 20, 2019 /PRNewswire/ - Baylis Medical announced today the first Arctic Front™ Advance Cryoballoon procedures performed using the VersaCross Transseptal Solution. The VersaCross solution ...

PENTAX Medical Company, a healthcare industry leader in diagnostic and therapeutic endoscopy, announces the introduction of the C2 CryoBalloon TM Ablation System for the treatment of Barrett’s ...

The VersaCross™ Transseptal Solution is available in Pigtail and J-tip RF wire configurations. (CNW Group/Baylis Medical Company Inc.) TORONTO, Nov. 20, 2019 /PRNewswire/ - Baylis Medical announced ...